XYLOSE
LOE Approachingxylose
NDAORALPOWDER
Approved
Mar 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xylose is an oral powder formulation of D-xylose, a pentose sugar used as a diagnostic and nutritional agent. It is primarily utilized in clinical settings for intestinal absorption testing and as a dietary supplement. The drug works through passive absorption in the small intestine, making it useful for assessing malabsorption disorders.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30), suggesting a mature market with limited growth opportunities for brand team expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Xylose offers limited career growth opportunities given zero linked job postings and an LOE-approaching lifecycle. This role is best suited for professionals seeking stability in a mature product rather than advancement in a high-growth franchise.
Product ManagerSales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.